Navigation Links
Current Regulatory Expectations Affecting the Validation of Reusable Medical Devices is Subject of Dec. 4th Seminar in Boston
Date:11/12/2013

AGAWAM, Mass., Nov. 12, 2013 /PRNewswire/ -- A half-day seminar focusing on current regulatory expectations in the validation of reusable medical devices is the subject of a seminar set for Dec. 4th in Waltham, Mass., near Boston.

The validation of reusable medical devices is at the forefront of the FDA's efforts to ensure patient safety. Requirements for the cleaning, disinfection, and sterilization of reusable devices are constantly changing. The situation challenges manufacturers both in terms of deciding which testing methods to employ as well as the planning of end points.

The seminar will provide attendees with the knowledge they need to know about current regulatory expectations so they may better prepare their submissions for FDA acceptance — and avoid the time-consuming and costly requirements of additional testing.

Seminar topics will include:

  • Discussion of the FDA's draft guidance for industry and FDA staff, "Processing/ Preprocessing Medical Devices in Healthcare Settings"
  • Methods used for the cleaning and validation of reusable devices
  • Methods for the disinfection of reusable devices
  • Methods for the sterilization of reusable devices
  • Testing requirements
  • Detailed discussion of endpoints for cleaning validation

The seminar will be presented by Microtest Laboratories, a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries, on Wednesday, Dec. 4, 2013, from 9 a.m. to 1 p.m. at the Conference Center at Waltham Woods in Waltham, Mass., just outside Boston. Registration is at 9 a.m. A continental breakfast, break refreshments, and a luncheon are included.

To register, visit 

SOURCE Microtest Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
2. Thomson Reuters Annual Pharmaceutical Factbook Reveals Key Insights into Current Trends
3. The New Generation of Antibody Therapeutics: Current Status and Future Prospects - Overview
4. Pharma IQs Laboratory Informatics Report: Current Trends & Predictions for 2015
5. ECRI Institute Helps Hospitals Design Spaces for Current and Future Technologies
6. Branded Generics in South East Asia: Current and Future Opportunities
7. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
8. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
9. Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation
10. Novel Apolipoprotein A-I Therapy, CSL112, May Represent New Option for Reducing Recurrent Heart Attack Risk, Early CSL Studies Show
11. Valeritas Announces The Publication Of A Retrospective Analysis Of Patient-Reported Data On The V-Go In The Current Issue Of Endocrine Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor ... announced the set-up of an optical biopsy program at ... de Grenoble is now the first hospital in ... interventional pulmonology and urology patients an innovative platform for ... to the endomicroscopy technology developed by Mauna Kea Technologies. ...
(Date:3/31/2015)... 30, 2015 Research and Markets ( ... "Global Nuclear Imaging Market 2015-2019" report to their ... Imaging market to grow at a CAGR of 5.89 ... The report, Global Nuclear Imaging market 2015-2019, has been ... from industry experts. The report covers the Americas, and ...
(Date:3/31/2015)... DUBLIN , Mar. 27, 2015 Research and ... addition of the "Intraoperative Imaging Market by Type ... to 2019" report to their offering. ... at a CAGR of 3.5% from 2014 to 2019 ... future due to a number of forces that favor ...
Breaking Medicine Technology:Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 2Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 3Global Nuclear Imaging Market 2015-2019 with GE healthcare, Philips Healthcare & Siemens Healthcare Dominating 2Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market 2015-2019 2
... DALLAS, January 5, 2012 The " ... Billing & Coding) and Pharmaceutical (Clinical trial & Contract manufacturing) ... " analyzes and studies the major market drivers, restraints, ... and Rest of the world. Browse ...
...  The Musculoskeletal Transplant Foundation (MTF) has announced the release of ... kits. The new sizes--16cm x 20cm and 20cm x 20cm--are ... and their patients. This unique human dermal allograft is specifically ... It has been a year since MTF introduced its bi-lateral ...
Cached Medicine Technology:MarketsandMarkets: Global Healthcare BPO Market worth $330 Billion by 2016 2MarketsandMarkets: Global Healthcare BPO Market worth $330 Billion by 2016 3New, Larger, Bilateral Breast Graft Kits Announced by MTF 2
(Date:4/1/2015)... 2015 Amada Senior Care , premier ... recently opened a new office in Rocky Mount, NC – ... Lee Bissett decided to make the move to senior care ... over 20 years of experience in management and consulting. Their ... , When asked what makes Amada different from other ...
(Date:4/1/2015)... San Francisco based sustainable medical apparel manufacturer, ... Operation Smile, have launched a yearlong campaign ... RxOrganics is generously donating 5% of all purchases ... throughout 2015. RxOrganics has committed to an uncapped annual ... order placed online through the Rxmedical shop will have ...
(Date:4/1/2015)... 2015 Results are in for the ... featured 11 new homes from across the state exemplifying ... utilized innovative building techniques and new technology intended to ... Associates, Inc. (SWA) provided sustainability consulting services for 4 ... including the first- and third-place winners. , The Benker ...
(Date:4/1/2015)... Oak Brook, IL (PRWEB) April 01, 2015 ... unfortunately benefited greatly from climate change in recent years, ... will develop an allergic reaction if exposed to poison ... as outdoor enthusiasts and families prepare for summer adventures ... of an uncomfortable poison plant reaction is greater than ...
(Date:3/31/2015)... 2015 Bon Secours New York Health ... Schervier Nursing Care Center family last week. The Sisters ... in Yonkers which is scheduled to close later this ... of the Sisters of Charity of New York, the ... to place their Sisters at Schervier Nursing Care Center ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Eastern North Carolina 2Health News:RxOrganics Forges Unique Partnership to Bring More Smiles to Underserved Global Heath Communities 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 3Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 4Health News:New Ivarest Poison Ivy Itch Spray Provides All-Day Comfort 2Health News:Bon Secours New York Health System Welcomes Retired Sisters of Charity to the Family 2
... ... is pleased to announce the addition of Brian Safier, MD, Allergist/Immunologist, who will join ENTA ... ... LLP (ENTA) is pleased to announce the addition of Brian Safier, MD, Allergist/Immunologist, who will ...
... which is the most common vascular complication after ... graft loss and devastating consequences. Surgical techniques are ... Despite improvements in surgical techniques, arterial reconstruction in ... With atraumatic microsurgical techniques, the reconstruction of HA ...
... of N-terminal pro-B-type natriuretic peptide (NT-proBNP, a protein thought ... robust, non-invasive predictor of cardiovascular (CV) risk in patients ... the results of a multinational study presented today at ... Against Rheumatism in Rome, Italy. The presence of ...
... ... like driving, especially those parents who live in areas where public transportation is limited or ... group in Walnut Creek and San Francisco to cope with this and many other dilemmas. ... Walnut Creek, CA (PRWEB) ...
... after new rules took effect, study finds , THURSDAY, ... to doctors who administer outpatient chemotherapy drugs actually led ... finds a new study. , "This sort of dynamic ... economists often encounter this sort of thing," Joseph Newhouse, ...
... ... that it has added a brand new 2009 Cessna Grand Caravan to its fleet of modern ... (PRWEB) June 17, 2010 ... that it has added a brand new 2009 Cessna Grand Caravan to its fleet of modern ...
Cached Medicine News:Health News:ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier, 2Health News:ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier, 3Health News:NT-proBNP is a predictor of CV risk in arthritis patients taking NSAIDs 2Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 2Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 3Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 4Health News:Medicare Cuts May Have Led Docs to Prescribe More Chemo 2Health News:Talon Air Adds A Brand New Cessna Grand Caravan Turbo Prop To Its Growing Private Jet Charter Fleet 2
Fenestrated 14 mm blades. Wide extension of blade for protection of lids. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: